Immune-based therapies are being explored on the presumption that host
response to HIV is central to the pathogenesis and progression of HIV
infection. Specific immune responses in most individuals serve to lim
it the acute stage of infection and induce a more chronic form of vira
l infection. Thus, immune response to HIV appears to be critical to vi
rus control. On the other hand, HIV infection induces widespread activ
ation of immune cells, which in turn contributes to further HIV produc
tion. Also, immune dysfunction contributes to the development of a num
ber of clinical disorders of AIDS, including opportunistic infections,
wasting syndrome, AIDS dementia complex, Kaposi's sarcoma and lymphop
roliferative disorders. Immune-based therapies in AIDS are directed at
answering 2 major questions. Can specific HIV immunity be manipulated
to better contain and reduce established HIV infection, and how can t
he pathogenic processes induced by HIV infection be reversed so as to
maintain or restore normal function and health? The interventions expl
ored thus far have been directed towards enhancement of specific immun
e mechanisms early in infection, restoration of defective functions an
d reduction of excessive activation secondary to cytokine derangement
in HN infection. Effective therapies developed to date include interfe
ron-alpha for Kaposi's sarcoma and intermittent interleukin-2 (5-day c
ourses every 8 weeks) to increase CD4+ counts. With greater understand
ing of the immunopathogenesis of HN infection, better focused and pote
ntially more effective therapies can be expected. Immune-based therapi
es are created from an understanding of the immunepathogenesis of HIV
infection. As knowledge of pathogenesis increases, more effective mean
s of controlling HIV replication and immune damage are det eloped. Imm
une therapies are also designed to maintain normal host immune functio
ns and thus reduce the likelihood of opportunistic diseases. However,
the immunopathogenic mechanisms underlying HIV infection and AIDS are
complex and involve multifaceted interactions of the virus with the im
mune system.